Mapi Ballester retweeted
Check out the recently published article by @mapibafe @BloomPringle & @C_F_Rose
'The Pros & Cons of Measuring Plasma Ammonia
in the Management of Patients With Cirrhosis: An
ISHEN Debate'
onlinelibrary.wiley.com/doi/…
Mapi Ballester retweeted
📌¡Ya disponible en el #RinconJoven de nuestra revista!
"Redefiniendo el papel del TIPS en la cirrosis: de la descompresión portal a la recompensación hepática".
Artículo 🔝 de @JoseSanchez118, @poyatos_paloma, @david_marti, Sheila González, @dmarti_aguado, Paloma Lluch y Pilar Ballester, del @GVAclinic ➡️
elsevier.es/es-revista-gastr…
Mapi Ballester retweeted
Ammonia
journals.lww.com/hepcomm/ful…
A magnum opus on a true liver function test / and liver toxin
The single greatest review on this important, controversial molecule. Rajiv Jalan AASLD Publications
Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHEN journal-of-hepatology.eu/art… @ISHENliver @C_F_Rose @RajivJalan1 @KarenLouiseTho2 @RocioGallegoD
Mapi Ballester retweeted
Un estudio de INCLIVA y la @UV_EG evidencia que la cirugía bariátrica mejora la función cognitiva y la calidad de vida en personas con enfermedad hepática metabólica y obesidad
🔗incliva.es/un-estudio-eviden…
Mapi Ballester retweeted
Our Phase 2a RCT of oral #YAQ007 vs rifaximin in cirrhosis is live in @HEP_Journal 🧵
✅ Significant ammonia reduction at ≥4g BID (p=0.002) - significantly better than Rifaximin + lactulose
✅ PAGN excretion ↑ in all groups — mechanism confirmed
✅ Generally well tolerated
No approved ammonia-targeting drug exists yet. This is a step.
doi.org/10.1097/HEP.00000000…
@AASLDtweets @EASLnews @MNK_Pharma @uclnews
#HepaticEncephalopathy #Cirrhosis @HEP_Journal #LiverDisease @YaqritLtd @ISHENliver
Mapi Ballester retweeted
🎙️Patricia Fernández, adjunta a la Dirección Científica de INCLIVA, y la investigadora Mapi Ballester, del Grupo de Deterioro Neurológico, hablan del Proyecto Futura para el liderazgo de investigadoras en 'La 8 Mediterráneo'
📺8tv-videos.b-cdn.net/9320261…
(A partir del minuto 39’30”)
Science, nature and fun! All together at #ISHEN2025 in Montreal! Thanks to our president @C_F_Rose @ISHENliver @ISHENtranslatio @GrupoJovenAEEH
Mapi Ballester retweeted
👏🏻 Felicitamos a Concepción Gómez (Laboratorio de Deterioro Neurológico UV-INCLIVA) por la defensa de su tesis doctoral 'Estudio de las alteraciones neurológicas y bioquímicas en pacientes con obesidad mórbida y enfermedad hepática metabólica. Impacto de la cirugía bariátrica'.
Join us at the poster tour: cirrhosis and its complications. Track Hub 4, Friday 16:15-17:00 CEST. #AMMON to predict liver-related complications 🎯 @EASLnews @ReibergerThomas @RajivJalan1
Mapi Ballester retweeted
Brilliant oral presentation by @mapiBallester about AMMON-OHE model to predict decompensation beyond HE @AEEHLiver @GrupoJovenAEEH @EASLedu @RajivJalan1 AMMON-OHE works!! 👏👏🔟👏👏 great!!
Mapi Ballester retweeted
Modelo AMMON-OHE presenta una gran capacidad predictiva para descompensación hepática y mortalidad. Gran trabajo colaborativo de @mapibafe #AEEH2025 @AEEHLiver
Mapi Ballester retweeted
📢👌Just released: Ammonia and Beyond: biomarkers of hepatic encephalopathy (HE).🧠
👉different approaches to predict overt HE
👉Free download at: rdcu.be/d6NpO
@AEEHLiver @uchceu @mapibafe @GVAdsarnau
#inflammation #cirrhosis #microbiota #braininjury
Mapi Ballester retweeted
📣 ISHEN is coming to Canada 🇨🇦
👉 SAVE THE DATE: October 5-8th
Receive updates via monthly ISHEN newsletter:
✅ Registration + abstract deadlines
✅ Scientific program
Become a member today!
ishen.org/join-us/
@EASLnews @AASLDtweets @CASLupdates
Mapi Ballester retweeted
📣Absolutely thrilled with our last review published in @NatRevGastroHep Ammonia plays a major role in MASLD progression &HE: therapeutic target. Tremendous effort by @RocioGallegoD and @AHadjihambi @RajivJalan1 @Dr_Ampuero @C_F_Rose 👏🔟🔝@saludand @ibis_sevilla @unisevilla
Gracias a @incliva por el premio postdoctoral🥇en la II edición de los premios para mujeres investigadoras incliva.es/maria-pilar-balle…
Sarcopenia in patients with cirrhosis is associated with higher risk of decompensation including HE and death 💪🤯 how to evaluate and treat it is being reviewed by @aldomontanoloza in @ISHENtranslatio
Exercise has many beneficial effects on the brain 🏋️♂️🧠 pathophysiological mechanisms are being discussed by Johannes Burtscher in @ISHENtranslatio
Mapi Ballester retweeted
#LiverTwitter
❓
Is there or is there not ...
a value of Ammonia #NH3 Testing in Clinical Practice
❓
sciencedirect.com/science/ar…

































